Market News & Trends
Volume Rises, Value Falls for M&A Deals in Global Pharmaceutical & Biotechnology Industry
The challenges posed by expiring patents, the global economic slowdown, and price premium pressures are forcing the pharmaceutical and biotech industry to restructure and streamline…
Eurofins Signs Agreement to Acquire ViraCor-IBT Laboratories
Eurofins Scientific, a global leader in bioanalytical testing and one of the world leaders in genomic services, has signed a definitive agreement to acquire ViraCor-IBT…
Ligand Signs $4.5-Million Agreement With Omthera Pharmaceuticals
Ligand Pharmaceuticals Incorporated recently announced it has entered into a licensing agreement and research collaboration with Omthera Pharmaceuticals, Inc., a wholly owned subsidiary of AstraZeneca…
EMD Millipore Expands Provantage Upstream Bioproduction Services to North American Market
EMD Millipore recently announced the expansion of its upstream services into North America as part of its Provantage Biodevelopment and Clinical Supply offering. The company’s…
Volume Rises, Value Falls for M&A Deals in Global Pharmaceutical & Biotechnology Industry
The challenges posed by expiring patents, the global economic slowdown, and price premium pressures are forcing the pharmaceutical and biotech industry to restructure and streamline…
Akorn to Acquire VersaPharm for $440 Million
Akorn, Inc. recently announced it has entered into a definitive agreement to acquire VPI Holdings Corp., the parent company of VersaPharm Incorporated, for $440 million…
Lundbeck to Acquire Chelsea Therapeutics in $658-Million Deal
H. Lundbeck A/S and Chelsea Therapeutics International, Ltd. recently announced the companies have entered into a definitive agreement under which Lundbeck will acquire Chelsea. Under…
Anokion Secures $37.5 Million, Big Names Invest
Anokion SA recently announced it has successfully closed a Series A financing round for $37.5 million. A group of leading life sciences venture capitalists, consisting…
Avantor Appoints New Chief Executive Officer
Avantor Performance Materials recently announced the appointment of Michael Stubblefield as its new Chief Executive Officer. Mr. Stubblefield assumes the role of CEO from Richard…
Horizon Discovery Licenses Gene Editing Technology From ERS Genomics
Horizon Discovery Group plc recently announced it has entered into a non-exclusive license agreement with ERS Genomics Ltd (ERS) to access intellectual property (IP) relating…
Arcadia Biosciences Raises $33 Million
Arcadia Biosciences, Inc. recently announced it has closed on a $33-million round of Series D preferred share equity financing. The round was led with an…
Regeneron & Avalanche to Develop Next-Generation Gene Therapy Products
Regeneron Pharmaceuticals, Inc. and Avalanche Biotechnologies, Inc. recently announced the formation of a broad collaboration to discover, develop, and commercialize novel gene therapy products for…
Indonesian Pharmaceutical Market Sees Rapid Expansion
Driven by increased government healthcare spending and growing life expectancy, the Indonesian pharmaceutical market value will climb from approximately $5 billion in 2013 to $9.9…
Growth Foreseen at All Levels of the Oral Solid Dosage Form Excipients Market
On a global scale, the oral solid dosage form (OSDF) excipients market is growing sustainably, historically exhibiting a robust increase. This market is valued at…
Novozymes A/S to Build $36-Million Facility, Create 100 R&D Jobs in the US
Novozymes recently announced the establishment of a new R&D center in the US dedicated to its bioagriculture business. The center will be located near the…
Capsugel Enters Agreement With Chiasma
Capsugel recently announced an agreement with Chiasma, Inc., wherein Capsugel’s Dosage Form Solutions (DFS) business unit is scaling up manufacturing for the only investigational oral…
Hollow Microstructured Transdermal System Available for Use in Preclinical Studies
3M Drug Delivery Systems Division recently announced the availability of the 3M hollow microstructured transdermal system (hMTS) for pharmaceutical and biotech companies interested in conducting…
SMARTT e-Patch: A New Electronic Transdermal Patch
Rhenovia Pharma recently announced that its SMARTT e-Patch project has won an award at the World Innovation Challenge founded by the President of France to…
Novozymes' Half-Life Extension Technology Reaches Landmark Milestone Approval
The US FDA has granted marketing approval to GlaxoSmithKline's new type 2 diabetes drug, branded Tanzeum in the US and Eperzan in Europe, which uses…
Emerging Technologies Redefine Infectious Disease Diagnostics
The diagnostics market for infectious diseases, such as tuberculosis (TB), human immunodeficiency virus (HIV), hepatitis C virus, and human papilloma virus is expanding, giving rise…